MedPath

Effectiveness of repairing the heart valve with CardioCel®

Not Applicable
Recruiting
Conditions
Tricuspid Regurgitation
Cardiovascular - Other cardiovascular diseases
Surgery - Surgical techniques
Registration Number
ACTRN12620000564954
Lead Sponsor
The Alfred
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Is ambulatory, able and willing to comply with the study protocol and has provided written informed consent

Aged 18-85 years, inclusive

Symptomatic with TR grade greater than or equal to 3+

Preserved right ventricular function

In the opinion of the investigator and heart surgery team, the patient is not an appropriate candidate for tricuspid annuloplasty

Exclusion Criteria

In the opinion of the investigator and heart surgery team, the patient is an appropriate candidate for tricuspid annuloplasty

Haemodynamic instability (systolic pressure < 90mmHg without after load reduction or cardiogenic shock or the need for inotropic support or intra-aortic balloon pump)

Model for End-stage Liver Disease (MELD score) > 15

Suspected inability to adhere to adhere to follow-up

Patients in whom TTE, TOE, (or MRI) is contraindicated

A known need for any other cardiac surgery

Inability to give informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Residual tricuspid regurgitation on TTE<br><br>[12 months and 24 months postoperatively];Right ventricular function on TTE[12 months and 24 months postoperatively]
Secondary Outcome Measures
NameTimeMethod
Reintervention for tricuspid valve will be assessed by patient medical records[12 months and 24 months postoperatively];Permanent pacemaker implantation will be assessed by patient medical records[12 months and 24 months postoperatively];Prosthetic valve infection will be assessed by patient medical records[12 months and 24 months postoperatively]
© Copyright 2025. All Rights Reserved by MedPath